The Bcl-2/Beclin-1 Interaction. Bcl-2 family proteins (BNIP3, Bad,... | Download Scientific Diagram
JCI - Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737
Efficacy and specificity of inhibitors of BCL-2 family protein interactions assessed by affinity measurements in live cells | Science Advances
Life | Free Full-Text | BH3-Only Proteins Noxa and Puma Are Key Regulators of Induced Apoptosis
Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1 | eLife
Basal Patologi KU - BAD, BID and PUMA proteins shift the balance between the pro-apoptotic and anti-apoptotic family members by neutralizing the actions of anti-apoptotic proteins like BCL2 and BCL-XL, thereby promoting
BCL2‑regulated apoptotic process in myocardial ischemia‑reperfusion injury (Review)
Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins | PNAS
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics. - Abstract - Europe PMC
The Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and Treatment - Rana Elkholi, Konstantinos V. Floros, Jerry E. Chipuk, 2011
Interplay of Bcl-2 Proteins Decides the Life or Death Fate
PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors
Recombinant Human PUMA protein (ABIN2468998)
![PDF] The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bc1b604df6bc10689692a528b2f985421ba3227d/2-Figure1-1.png "PDF] The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms | Semantic Scholar")
PDF] The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms | Semantic Scholar
A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia | Cancer Gene Therapy
Targeting BCL-2 regulated apoptosis in cancer | Open Biology
Overview of BCL-2 Family Proteins and Therapeutic Potentials | SpringerLink
BCL-2
Life | Free Full-Text | BH3-Only Proteins Noxa and Puma Are Key Regulators of Induced Apoptosis
Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications - ScienceDirect
Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context | Egyptian Journal of Medical Human Genetics | Full Text
IJMS | Free Full-Text | Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer
Determination of the expression of PUMA and Bcl-2 in UM | Open-i
BCL-2 family: integrating stress responses at the ER to control cell demise. - Abstract - Europe PMC
A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia | Cancer Gene Therapy
Frontiers | Targeting the Bcl-2 Family in B Cell Lymphoma
